EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Increased mortality in polycystic ovary syndrome— a cohort study

Terhi T Piltonen iD, Noona Koskenkari, Emilia Koivuaho, Laure Morin-Papunen, Elisa Hurskainen, Mika Gissler iD, Riikka K Arffman iD, Meri-Maija Ollila iD

European Journal of Endocrinology · 30.04.2026 · 194 (5) · 724-731

DOI: 10.1093/ejendo/lvag080 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift European Journal of Endocrinology, online erschienen am 29.05.2026. Verfasst von Terhi T Piltonen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Oulu University Hospital, Oulu 90220, Finland. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Research Council of Finland, Sigrid Jusélius Foundation, Finnish Diabetes Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Polycystic ovary syndrome (PCOS) is associated with high comorbidity risk, whereas the data on mortality are inconsistent. The objective was to investigate all-cause and cause-specific mortality risks in women with PCOS.

Design

A cohort study utilizing 1:3 matched cases and controls. The follow-up started at the diagnosis of PCOS.

Methods

All women with ICD 8-10 codes for PCOS during January, 1, 1969 to December, 31, 2019 were identified from Finnish nationwide health-care records (N = 9839). Women with PCOS were compared to age and residential area-at-birth-matched control women who did not have a PCOS diagnosis (N = 28 238). Crude and adjusted Cox proportional hazards models were fitted, adjusting for education level and diagnosed conditions (obesity, type 2 diabetes, and hypertension; yes vs no). The results were reported as hazard ratios (HRs) with 95% confidence intervals.

Results

During the median follow-up time of 12 years, 2.02% (n = 199/9839) of women with PCOS had died compared to 1.43% (n = 403/28 238) of controls. Women with PCOS had increased overall mortality after adjusting for education level, obesity, type 2 diabetes, and hypertension (adjusted HR = 1.33 [1.12-1.59]). Mortality due to neoplasms (education adjusted HR = 1.39 [1.04-1.86]) and diseases of the circulatory system (education adjusted HR = 1.68 [1.14-2.50]) was increased. Additionally, mortality due to endocrine, nutritional, and metabolic diseases was increased in the unadjusted model (HR = 2.48 [1.03-5.98]), but not in the education-adjusted model.

Conclusions

The results suggest that women with PCOS have an increased overall mortality compared to women without PCOS. Effective strategies to reduce mortality risk in women with PCOS should be investigated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeHumansFemaleAdultCohort StudiesFinlandDiabetes Mellitus, Type 2ObesityMiddle AgedYoung AdultFollow-Up StudiesCause of DeathCase-Control StudiesRisk Factors

Stichwörter der Autor:innen

PCOSall-cause mortalitycause-specific mortalitycohort study

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Oulu University Hospital, Oulu 90220, Finland.
  • Medical Research Center Oulu, Research Unit of Clinical Medicine, University of Oulu, Oulu 90220, Finland.
  • Department of Data and Analytics, Finnish Institute for Health and Welfare, PO Box 30, Helsinki 00271, Finland.
  • Region Stockholm, Academic Primary Health Care Centre, Stockholm 113 65, Sweden.
  • Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm 171 76, Sweden.
  • Department of Internal Medicine, Oulu University Hospital, Oulu 90220, Finland.

ORCID-Profile: Terhi T Piltonen, Mika Gissler, Riikka K Arffman, Meri-Maija Ollila

Förderung

  • Research Council of Finland
  • Sigrid Jusélius Foundation
  • Finnish Diabetes Research Foundation
  • Sakari Alhopuro Foundation
  • Medical Research Center Oulu
  • Novo Nordisk Foundation
  • Roche Diagnostics International

Zitieren

APA

Piltonen, T. T., Koskenkari, N., Koivuaho, E., Morin-Papunen, L., Hurskainen, E., Gissler, M., Arffman, R. K., & Ollila, M. M. (2026). Increased mortality in polycystic ovary syndrome— a cohort study. European Journal of Endocrinology, 194(5), 724-731. https://doi.org/10.1093/ejendo/lvag080

Vancouver

Piltonen TT, Koskenkari N, Koivuaho E, Morin-Papunen L, Hurskainen E, Gissler M, et al. Increased mortality in polycystic ovary syndrome— a cohort study. European Journal of Endocrinology. 2026;194(5):724-731. doi:10.1093/ejendo/lvag080

BibTeX
@article{Piltonen2026,
  author = {Piltonen, Terhi T and Koskenkari, Noona and Koivuaho, Emilia and Morin-Papunen, Laure and Hurskainen, Elisa and Gissler, Mika and Arffman, Riikka K and Ollila, Meri-Maija},
  title = {Increased mortality in polycystic ovary syndrome— a cohort study},
  journal = {European Journal of Endocrinology},
  year = {2026},
  volume = {194},
  number = {5},
  pages = {724--731},
  doi = {10.1093/ejendo/lvag080}
}
Kostenlos starten →